134 related articles for article (PubMed ID: 12238845)
21. Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators.
Zimmermann AK; Weber N; Aebert H; Ziemer G; Wendel HP
J Biomed Mater Res B Appl Biomater; 2007 Feb; 80(2):433-9. PubMed ID: 16850460
[TBL] [Abstract][Full Text] [Related]
22. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
[TBL] [Abstract][Full Text] [Related]
24. Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass.
Saito N; Motoyama S; Sawamoto J
Artif Organs; 2000 Jul; 24(7):547-54. PubMed ID: 10916066
[TBL] [Abstract][Full Text] [Related]
25. Changes in platelet aggregation during cardiopulmonary bypass: comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material.
Izuha H; Hattori M; Igari T; Wakamatsu D; Watanabe M; Yokoyama H
J Artif Organs; 2005; 8(1):41-6. PubMed ID: 15951979
[TBL] [Abstract][Full Text] [Related]
26. Poly-2-methoxyethylacrylate-coated bypass circuits reduce activation of coagulation system and inflammatory response in congenital cardiac surgery.
Suzuki Y; Daitoku K; Minakawa M; Fukui K; Fukuda I
J Artif Organs; 2008; 11(3):111-6. PubMed ID: 18836870
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model.
Suhara H; Sawa Y; Nishimura M; Oshiyama H; Yokoyama K; Saito N; Matsuda H
Ann Thorac Surg; 2001 May; 71(5):1603-8. PubMed ID: 11383807
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of minimized extracorporeal circulation in high-risk coronary revascularization: impact on air handling, inflammation, hemodilution and myocardial function.
Gunaydin S; Sari T; McCusker K; Schonrock U; Zorlutuna Y
Perfusion; 2009 May; 24(3):153-62. PubMed ID: 19755462
[TBL] [Abstract][Full Text] [Related]
29. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
30. Biocompatibility of cardiopulmonary bypass circuit with new polymer Senko E-Ternal Coating™.
Fukui T; Nishida H; Takanashi S
Perfusion; 2015 Oct; 30(7):572-9. PubMed ID: 25837980
[TBL] [Abstract][Full Text] [Related]
31. Effect of surface coating on platelet count drop during cardiopulmonary bypass.
Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Gustafson PA
Perfusion; 1999 May; 14(3):195-200. PubMed ID: 10411249
[TBL] [Abstract][Full Text] [Related]
32. Effect of Carmeda BioActive Surface coating versus Trillium Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass.
Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Elmore BA; Gustafson PA; Castagna JM
Perfusion; 2001 Jul; 16(4):279-83. PubMed ID: 11486846
[TBL] [Abstract][Full Text] [Related]
33. A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit.
Palatianos GM; Foroulis CN; Vassili MI; Astras G; Triantafillou K; Papadakis E; Lidoriki AA; Iliopoulou E; Melissari EN
Ann Thorac Surg; 2003 Jul; 76(1):129-35. PubMed ID: 12842526
[TBL] [Abstract][Full Text] [Related]
34. Humoral immune response and coated or uncoated oxygenators during cardiopulmonary bypass surgery.
Karakisi SO; Kunt AG; Bozok Ş; Çankaya İ; Kocakulak M; Muşabak U; Sargon MF; Ergene Ş; İlhan G; Karamustafa H; Tufekci N; Şener E
Cardiovasc J Afr; 2016; 27(4):242-245. PubMed ID: 27841912
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronan based heparin free coated open and closed extracorporeal circuits for high risk coronary revascularization.
Gunaydin S; Ucar HI; Serter T; McCusker K; Ozcelik G; Salman N; Yorgancioglu AC
J Extra Corpor Technol; 2010 Dec; 42(4):286-92. PubMed ID: 21313926
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
37. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
[TBL] [Abstract][Full Text] [Related]
38. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Mimesys phosphorylcholine (PC)-coated oxygenators during cardiopulmonary bypass in adults.
Myers GJ; Johnstone DR; Swyer WJ; McTeer S; Maxwell SL; Squires C; Ditmore SN; Power CV; Mitchell LB; Ditmore JE; Aniuk LD; Hirsch GM; Buth KJ
J Extra Corpor Technol; 2003 Mar; 35(1):6-12. PubMed ID: 12680489
[TBL] [Abstract][Full Text] [Related]
40. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
